CEDAR KNOLLS, NJ--(Marketwired - May 19, 2015) - MYOS Corporation ("MYOS" or the "Company") (
Rē Muscle Health™ is a new product line that helps rebuild, rejuvenate and maintain lean muscle and is designed for individuals who want an all-natural product with clinically proven results. Fortetropin®, the active ingredient in Rē Muscle Health™, is clinically proven to build healthy lean muscle. It accomplishes this through a fertilized egg based protein and lipid complex that increases protein synthesis and inhibits muscle degradation pathways.
Rē Muscle Health™ products contain 20 grams of protein to help protect, preserve and promote healthy lean muscle. Rē Muscle Health™ Bars, powders and meal replacement shakes can be used daily:
- To increase both muscle thickness and lean body mass
- For workout recovery -- protein helps promote muscle recovery and growth
- As a snack or meal replacement
The Rē Muscle Health™ Series comes in six flavors, and can be ordered online at www.remusclehealth.com.
Dr. Aldrin commented, "I recognize the importance of maintaining muscle health and maximizing muscle performance. Given the extraordinary rigors of space travel on the human body, as well as the physical challenges of living in a zero gravity environment, unraveling the biology around muscle loss occurring during weightlessness and as a consequence of illness and immobility is one of the great opportunities I see for MYOS to develop therapeutic solutions in the future."
"MYOS is doing important, groundbreaking work in muscle health, and I rely on Re Muscle Health™ products to help me maintain my lean muscle, they taste great and I've seen tremendous results." Dr. Aldrin, a former intercollegiate athlete and pole vaulter, also noted, "I am pleased that Re Muscle Health™ is tailored to the aging population as well as athletes and the fitness community."
Chairman of MYOS Robert J. Hariri, M.D., Ph.D., commented "I am delighted to have Buzz as a member of the MYOS Board of Directors and as an advocate for our Re Muscle Health™ products. Buzz is a true American hero, a distinguished leader and businessman, a great mentor to me personally and an example of how physically active we can all be throughout our lives. I can tell you that Dr. Aldrin's demanding physical lifestyle in his 80's is an example of what we all should aspire to maintain."
About Buzz Aldrin
Buzz was educated at the U.S. Military Academy at West Point, graduating third in his class with a B.S. in mechanical engineering. He then joined the Air Force, serving as a combat pilot in Korea where he was decorated with the Distinguished Flying Cross and later retired with the rank of Colonel. He went on to earn his Doctorate of Science in Astronautics at the Massachusetts Institute of Technology and wrote his thesis on manned orbital rendezvous. Selected as an astronaut by NASA in 1963, Aldrin was the first astronaut with a doctorate.
In 1966 on the Gemini 12 orbital mission, Buzz performed the world's first successful spacewalk, overcoming prior difficulties experienced by Americans and Russians during extra-vehicular activity (EVA), and setting a new EVA record of 5 1/2 hours. On July 20, 1969, Buzz and Neil Armstrong made their historic Apollo 11 moonwalk, becoming the first two humans to set foot on another world. They spent 21 hours on the lunar surface and returned with 46 pounds of moon rocks. An estimated 600 million people -- at that time, the world's largest television audience in history -- witnessed this unprecedented heroic endeavor. Upon returning from the moon, Buzz was decorated with the Presidential Medal of Freedom, the highest American peacetime award.
Since retiring from NASA and the Air Force, Dr. Aldrin has remained at the forefront of efforts to ensure America's continued leadership in human space exploration. He devised a master plan for missions to Mars known as the "Aldrin Mars Cycler" -- a spacecraft system with perpetual cycling orbits between Earth and Mars. Dr. Aldrin has received three U.S. patents for his schematics of a modular space station, Starbooster reusable rockets, and multi-crew modules for space flight. He founded Starcraft Boosters, Inc., a rocket design company, and the ShareSpace Foundation, a nonprofit devoted to advancing space education, exploration and affordable space flight experiences for all. Dr. Aldrin is an author of seven books including his New York Times bestselling autobiography titled, "Magnificent Desolation" which was released in 2009. For more information, please visit www.buzzaldrin.com.
About MYOS Corporation
MYOS is an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases. MYOS is the owner of Fortetropin®, the first clinically proven natural myostatin inhibitor. Myostatin is a natural regulatory protein, which inhibits muscle growth and recovery. Medical literature suggests that lowering myostatin levels has many potential health benefits including increased muscle mass, healthy weight management, improved energy levels, stimulation of muscle healing as well as treating sarcopenia, a condition of age-related loss of muscle mass. To discover why MYOS is known as "The Muscle Company,"™ visit www.myoscorp.com
About Rē Muscle Health™
The Rē Muscle Health™ series is the Company's first branded line of muscle health products. This unique line of all-natural, non-GMO products contain Fortetropin®, an egg-based, all natural myostatin inhibitor clinically proven to build healthy muscle. The Rē Muscle Health™ series can be ordered by visiting www.remusclehealth.com. MYOS believes that Fortetropin®, as well as future products it envisions, will redefine existing standards for muscle health. The Rē Muscle Health™ product line is owned and sold directly by the Company. www.remusclehealth.com
Any statements in this release that are not historical facts are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to those relating to the successful continued research of Fortetropin® and its effects on myostatin inhibition, inflammatory cytokine levels and cholesterol levels, the successful launch and customer demand for our Rē Muscle Health™ and other products, the continued growth of repeat purchases, market acceptance of our existing and future products, the ability to create new products through research and development, growth in our revenue, the successful entry into new markets including the age management market, the ability to collect our accounts receivable from our distributors, our ability to raise capital to fund continuing operations, the ability to attract additional investors and increase shareholder value, the ability to generate the forecasted revenue stream and cash flow from sales of Fortetropin® and Rē Muscle Health™, the ability to achieve a sustainable profitable business, the effect of economic conditions, the ability to protect our intellectual property rights, the ability to maintain and expand our manufacturing capabilities and reduce the costs of our products, the ability to comply with NASDAQ's continuing listing standards, competition from other providers and products, risks in product development, and other factors discussed from time to time in our Securities and Exchange Commission filings. We undertake no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law.
These statements have not been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure or prevent any disease.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2825005